AT Alpha Tau Medical Ltd. Stock: price and management transactions · United States · SEC (Form 4)Follow the Alpha Tau Medical Ltd. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €1.4bn. The latest transaction was reported on 25 August 2026 (Levée d'options). Among the most active insiders: Levy Raphi. The full history is openly available.
€786,180
12 ops.
Sell Volume
Analyst consensus: bullish or bearish? Analysts rate Alpha Tau Medical Ltd. Buy (bullish), based on 5 analysts. Average price target: US$14.40.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 25 August 2026
All Executives24 Thresholds0 Prospectus0 Other0
Declarations 24 total
◇ Chief Financial Officer · Executives · 21 Aug 2026
2,871 shares @ US$2.98 0.0006% mcap 0.3% of flow Ordinary Shares SEC:0001213900-26-093335:0
▼ Chief Financial Officer · Executives · 21 Aug 2026
2,871 shares @ US$15.0028 0.0031% mcap 1.7% of flow Ordinary Shares SEC:0001213900-26-093335:1
● Officer · Executives · 21 Aug 2026
5,000 shares @ US$14.36 0.0054% mcap 100.0% of flow Ordinary Shares SEC144:0001976408-26-000759
◇ Chief Financial Officer · Executives · 11 Aug 2026
17,730 shares @ US$2.98 0.0044% mcap 2.2% of flow Ordinary Shares SEC:0001213900-26-088176:0
▼ Chief Financial Officer · Executives · 11 Aug 2026
17,730 shares @ US$14.0032 0.021% mcap 10.3% of flow Ordinary Shares SEC:0001213900-26-088176:1
◇ Chief Financial Officer · Executives · 6 Jul 2026
2,270 shares @ US$2.98 0.0006% mcap 1.0% of flow Ordinary Shares SEC:0001213900-26-075747:0
▼ Chief Financial Officer · Executives · 6 Jul 2026
2,270 shares @ US$14.0011 0.0026% mcap 4.7% of flow Ordinary Shares SEC:0001213900-26-075747:1
● Officer · Executives · 6 Jul 2026
20,000 shares @ US$13.23 0.023% mcap 22.3% of flow Ordinary Shares SEC144:0001976408-26-000638
◇ Chief Financial Officer · Executives · 2 Jul 2026
17,873 shares @ US$2.98 0.0045% mcap 8.4% of flow Ordinary Shares SEC:0001213900-26-075309:0
▼ Chief Financial Officer · Executives · 2 Jul 2026
17,873 shares @ US$13.0027 0.019% mcap 36.8% of flow Ordinary Shares SEC:0001213900-26-075309:1
● Officer · Executives · 1 Jul 2026
20,000 shares @ US$12.58 0.022% mcap 27.4% of flow Ordinary Shares SEC144:0001976408-26-000610
◇ Chief Financial Officer · Executives · 1 Jul 2026
2,127 shares Ordinary Shares SEC:0001213900-26-074749:0
▼ Chief Financial Officer · Executives · 1 Jul 2026
2,127 shares Ordinary Shares SEC:0001213900-26-074749:1
▼ Chief Financial Officer · Executives · 30 Jun 2026
20,000 shares Ordinary Shares SEC:0001213900-26-074011:0
● Officer · Executives · 30 Jun 2026
20,000 shares @ US$11.22 0.020% mcap 13.9% of flow Ordinary shares SEC144:0001976408-26-000605
● Officer · Executives · 25 Jun 2026
20,000 shares @ US$10.05 0.018% mcap 12.5% of flow Ordinary Shares SEC144:0001976408-26-000586
▼ Chief Financial Officer · Executives · 25 Jun 2026
4,222 shares Ordinary Shares SEC:0001213900-26-072349:0
▼ Chief Financial Officer · Executives · 25 Jun 2026
15,778 shares Ordinary Shares SEC:0001213900-26-072349:1
▼ Chief Financial Officer · Executives · 23 Jun 2026
15,000 shares Ordinary Shares SEC:0001213900-26-071830:0
▼ Chief Financial Officer · Executives · 23 Jun 2026
2,500 shares Ordinary Shares SEC:0001213900-26-071830:1
● Officer · Executives · 23 Jun 2026
17,500 shares @ US$10.03 0.015% mcap 9.8% of flow Ordinary Shares SEC144:0001976408-26-000583
● Officer · Executives · 3 Jun 2026
32,500 shares @ US$8.93 0.025% mcap 13.8% of flow Ordinary shares SEC144:0001976408-26-000546
▼ Chief Financial Officer · Executives · 3 Jun 2026
17,500 shares @ US$10.9005 54.2% of flow Ordinary Shares SEC:0001213900-26-065201:0
▼ Chief Financial Officer · Executives · 3 Jun 2026
15,000 shares @ US$10.7571 45.8% of flow Ordinary Shares SEC:0001213900-26-065201:1
关于 Alpha Tau Medical Ltd. Alpha Tau Medical Ltd. 是一家专注于利用阿尔法放射疗法技术开发创新癌症治疗方法的公司。该公司在纳斯达克上市，股票代码为 ATOU。